Haleon
About Haleon
Haleon is a British consumer-health company spun out of GSK, headquartered in Surrey, behind brands such as Sensodyne, Panadol, Voltaren and Centrum.
Milestones
Milestones as listed on sec.gov, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.
Leadership Team
Leadership as listed on sec.gov, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.
Products & Services
Products and services as listed on sec.gov, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.
Sensodyne
Specialist toothpaste brand for tooth sensitivity; Haleon reports it as global number one in sensitivity toothpaste.
Source: sec.govCentrum
Multivitamin brand Haleon describes as the world's leading multivitamin.
Source: sec.govVoltaren
Pain relief brand within Haleon's systemic and topical pain portfolio.
Source: sec.govOtrivin
Cough, cold and allergy brand, alongside Theraflu, Flonase and Robitussin.
Source: sec.govSites in Ireland
Dungarvan, Co. Waterford
One of Haleon's key in-house manufacturing sites; subsidiary Haleon Ireland Dungarvan Limited is based at Knockbrack.
Source: sec.govSites as listed on sec.gov, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.
Pipeline & Regulatory Record
What public registers list for Haleon: clinical trials it sponsors, FDA device clearances, Irish licences, recent approvals and supply shortages. Rebuilt daily, last on 11 Oct 2026.
Clinical trials 9 in our ClinicalTrials.gov registers
All trials by sponsor name 1 registry name
Drugs in these trials 1 compounds
Group (Haleon): headquarters Weybridge, website haleon.com. Wikidata Q112860932 · Wikipedia. From Wikidata (CC0), matched by the group's SEC filer number.
How this is matched: register records are linked to this page by the organisation name they carry, here HALEON; Haleon CH SARL; Haleon Ireland Limited. Spot a wrong match? Tell us.
Financials & Irish Entities
From the annual reports Haleon plc files with the US Securities and Exchange Commission (20-F, IFRS), in GBP as reported. Latest financial year: to Dec 2025.
| Year to | Revenue | R&D | R&D % | Net income | Filing |
|---|---|---|---|---|---|
| Dec 2025 | £11.03bn | £316m | 2.9% | £1.67bn | 20-F 2026 |
| Dec 2024 | £11.23bn | £298m | 2.7% | £1.44bn | 20-F 2026 |
| Dec 2023 | £11.30bn | £311m | 2.8% | £1.05bn | 20-F 2026 |
| Dec 2022 | £10.86bn | £300m | 2.8% | £1.06bn | 20-F 2025 |
| Dec 2021 | £9.55bn | £257m | 2.7% | £1.39bn | 20-F 2024 |
Each year is taken from the most recent annual report that includes it, so earlier years reflect any later restatement. Source: SEC EDGAR (XBRL financial data). Compare companies on the pharma company financials register.
Companies registered in Ireland 3 active in the CRO register
| Company | CRO no. | Registered | Last accounts |
|---|---|---|---|
| Haleon Ireland Limited LTD - Private Company Limited by Shares | 24797 | 1967 | Dec 2024 |
| Haleon Ireland Dungarvan Limited LTD - Private Company Limited by Shares | 268666 | 1997 | Dec 2024 |
| Haleon UK Trading Services Limited External company | 909993 | 2023 | — |
From the Companies Registration Office (CRO Open Data, CC BY 4.0). A company is listed when GLEIF's legal entity register links it to Haleon plc as its ultimate parent, or when we checked its name and registered address by hand. Branches of foreign companies appear as "External company". Spot a missing or wrong entry? Tell us.